Peptides
Evidence: moderate_human
GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic hexapeptide that stimulates GH release through activation of the growth hormone secretagogue receptor (GHS-R1a/ghrelin receptor) on pituitary somatotrophs. It acts via dual sites — pituitary and hypothalamic — possibly involving regulatory factors beyond GHRH and somatostatin. GHRP-6 also stimulates ghrelin-mediated appetite signaling, increases cortisol and prolactin release, and has demonstrated cytoprotective properties including cardioprotection.
Standard: Research indicates 100-300 mcg administered 1-3 times daily via subcutaneous injection.
Maintenance: Research indicates 100 mcg at bedtime.
Administration: subcutaneousintramuscular
Timing: On empty stomach, 30+ minutes before meals. Bedtime dose most important. The strong hunger effect makes pre-meal timing practical.
Duration: 8-16 week cycles.
GHRP-6 is the most potent appetite-stimulating GH secretagogue — this is either a feature or a bug depending on the client's goals. Useful for underweight clients or those needing caloric surplus for recovery, but problematic for those managing body composition. Less selective than Ipamorelin (raises cortisol and prolactin). Generally considered a second-line choice after Ipamorelin for most optimization protocols.
Compounding pharmacy or research-grade supplier with COA.
Take the free assessment and get personalized recommendations based on your biology and goals.
Get Your Free Protocolor take the assessment →